Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Retained Earnings (2022 - 2025)

Envoy Medical's Retained Earnings history spans 4 years, with the latest figure at -$120000.0 for Q3 2025.

  • For Q3 2025, Retained Earnings rose 99.96% year-over-year to -$120000.0; the TTM value through Sep 2025 reached -$120000.0, up 99.96%, while the annual FY2024 figure was -$123000.0, 99.95% up from the prior year.
  • Retained Earnings for Q3 2025 was -$120000.0 at Envoy Medical, up from -$297.9 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$116000.0 in Q3 2023 and bottomed at -$297.9 million in Q2 2025.
  • The 4-year median for Retained Earnings is -$24.3 million (2022), against an average of -$132.5 million.
  • The largest annual shift saw Retained Earnings tumbled 239161.21% in 2024 before it soared 99.96% in 2025.
  • A 4-year view of Retained Earnings shows it stood at -$226.0 million in 2022, then dropped by 13.84% to -$257.3 million in 2023, then surged by 99.95% to -$123000.0 in 2024, then grew by 2.44% to -$120000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Retained Earnings are -$120000.0 (Q3 2025), -$297.9 million (Q2 2025), and -$291.0 million (Q1 2025).